Who owns VISTAGEN THERAPEUTICS ORD?
- Ticker: VTGN
- CUSIP Number: 92840h400
Tip: Access positions for across all investors
Analyze quarterly positions in Vistagen Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Vistagen Therapeutics Ord stock
Who bought or sold VISTAGEN THERAPEUTICS ORD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 2.0M | $10M | 100% | Dec 2023 |
|
Dr. Jeffrey R. Jay, M.D. | 1.9M | $9.6M | 100% | Dec 2023 |
|
Vanguard Group | 1.8M | $9.4M | 623% | Dec 2023 |
|
Nantahala Capital Management | 1.8M | $9.3M | 100% | Dec 2023 |
|
Commodore Capital | 1.6M | $8.1M | 0% | Dec 2023 |
|
Citadel Advisors | 817k | $4.2M | 1095% | Dec 2023 |
|
Sphera Funds Management | 809k | $4.2M | 709% | Dec 2023 |
|
Susquehanna International | 586k | $3.1M | 17% | Mar 2024 |
|
ADAR1 Capital Management | 246k | $1.3M | 100% | Dec 2023 |
|
Two Sigma Investments | 192k | $987k | 100% | Dec 2023 |
|
Goldman Sachs Group | 164k | $842k | 100% | Dec 2023 |
|
BML Capital Management | 150k | $792k | 0% | Mar 2024 |
|
Bank Of Montreal | 97k | $524k | 100% | Dec 2023 |
|
Gts Securities | 85k | $439k | 100% | Dec 2023 |
|
William Blair $ Company | 69k | $362k | -22% | Mar 2024 |
|
DAFNA Capital Management | 42k | $215k | 100% | Dec 2023 |
|
Citigroup | 35k | $185k | -40% | Mar 2024 |
|
Charles Schwab Investment Management | 23k | $123k | 0% | Mar 2024 |
|
Barclays | 23k | $119k | 100% | Dec 2023 |
|
Jane Street | 22k | $113k | 100% | Dec 2023 |
|
Bank of America Corporation | 19k | $100k | 2965% | Dec 2023 |
|
Virtu Financial | 16k | $80k | 100% | Dec 2023 |
|
Advisor Group Holdings | 11k | $54k | 117% | Dec 2023 |
|
GPS Wealth Strategies Group | 8.4k | $45k | 0% | Mar 2024 |
|
CWM | 2.4k | $13k | -1% | Mar 2024 |
|
Royal Bank of Canada | 1.4k | $7.0k | -50% | Dec 2023 |
|
BFSG | 1.0k | $5.3k | 0% | Mar 2024 |
|
Wells Fargo & Company | 211.00 | $1.1k | 1% | Mar 2024 |
|
UBS Group | 117.00 | $601.005600 | -92% | Dec 2023 |
|
EverSource Wealth Advisors | 88.00 | $452.003200 | 0% | Dec 2023 |
|
Fairman Group | 29.00 | $153.001100 | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 16.00 | $82.000000 | 0% | Dec 2023 |
|
Who sold out of Vistagen Therapeutics Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Ikarian Capital | Sep 2023 | 229k | $1.2M |
Schonfeld Strategic Advisors | Sep 2023 | 139k | $726k |
Millennium Management | Sep 2023 | 17k | $88k |
Bank of New York Mellon | Dec 2023 | 15k | $78k |
Simplex Trading | Dec 2023 | 12k | $63k |
Janney Montgomery Scott | Dec 2023 | 10k | $51k |
Cutler | Dec 2023 | 200.00 | $1.0k |